Bora's Q1 EPS Hits 8-Year Low at NT$0.21, Shrinking 98% Year-on-Year
NQ Score
0/100
N1 Content Completeness
5
AI Summary (NQ-processed)
Bora Pharmaceuticals announced its first-quarter net profit attributable to the parent company was NT$25.83 million, a 98.1% decrease year-on-year, with an EPS of NT$0.21, an 8-year low. The company cited headwinds in the US generics market and plant maintenance but notes that orders are recovering.